6533b7dafe1ef96bd126e145

RESEARCH PRODUCT

Therapeutic Potential of Gammadelta T-Cells in Controlling CMV After Allogeneic Stem Cell Transplantation

S. Van DorpW.a. ScheperF.l. PietersmaD. Van BaarleBodo PlachterS. HeijhuursJ. KuballV. Marcu-malinaS. KerstingS. Hol

subject

TransplantationTransplantationbusiness.industryImmunologyGammadelta T CellsMedicineHematologyStem cellbusiness10.1016/j.bbmt.2010.12.195http://dx.doi.org/10.1016/j.bbmt.2010.12.195